JNJ
Johnson & Johnson
- Capital expenditures, FY2025
- $4.8B
- YoY, FY2025
- +9.2%
- 5-year CAGR
- +7.6%
- 10-year CAGR
- +3.4%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| FY2025 | $4.8B | +9.2% |
| FY2024 | $4.4B | −2.6% |
| FY2023 | $4.5B | +13.3% |
| FY2022 | $4.0B | +9.8% |
| FY2021 | $3.7B | +9.1% |
| FY2020 | $3.3B | −4.3% |
| FY2019 | $3.5B | −4.7% |
| FY2018 | $3.7B | +11.9% |
| FY2017 | $3.3B | +1.6% |
| FY2016 | $3.2B | −6.8% |
| FY2015 | $3.5B | −6.8% |
| FY2014 | $3.7B | +3.3% |
| FY2013 | $3.6B | +22.5% |
| FY2012 | $2.9B | +1.4% |
| FY2011 | $2.9B | +21.4% |
| FY2010 | $2.4B | +0.8% |
| FY2009 | $2.4B | −22.9% |
| FY2008 | $3.1B | +4.2% |
| FY2007 | $2.9B | — |